5. Hybrid Debt Instrument (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
|
Hybrid debt instruments outstanding | $ 0 | $ 0 | |
Loss on issuance of debt hybrid | $ 0 | $ (1,584,218) | |
Pharmsynthez [Member] | |||
Stock issued for convertible note, shares issued | 125,397 | ||
Hybrid Debt Instrument [Member] | Pharmsynthez [Member] | |||
Stock issued for convertible note, shares issued | 1,373,036 | ||
Stock issued for convertible note, amount converted | $ 6,500,000 | ||
Accrued interest converted | $ 200,000 |
X | ||||||||||
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Accrued interest converted No definition available.
|
X | ||||||||||
- Definition Gain (Loss) on issuance of hybrid debt instrument No definition available.
|
X | ||||||||||
- Definition Hybrid debt instruments outstanding No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|